AAPL332.27+5.70 (+1.75%) ▲|ABBV257.12+2.12 (+0.83%) ▲|ABT104.20+2.20 (+2.15%) ▲|ACN192.45+8.59 (+4.67%) ▲|ADBE263.36+11.13 (+4.41%) ▲|AMAT421.84-34.65 (-7.59%) ▼|AMD484.37-31.76 (-6.15%) ▼|AMGN380.36+3.01 (+0.80%) ▲|AMT177.54-0.33 (-0.19%) ▼|AMZN254.39-2.40 (-0.93%) ▼|AVGO347.05-14.95 (-4.13%) ▼|AXP326.50+1.82 (+0.56%) ▲|BA209.55-0.78 (-0.37%) ▼|BAC62.35-0.34 (-0.53%) ▼|BKNG180.52+6.60 (+3.79%) ▲|BLK1,075.02-4.57 (-0.42%) ▼|BMY64.64+1.02 (+1.60%) ▲|BNY160.77-1.90 (-1.17%) ▼|BRK-B513.81+3.47 (+0.68%) ▲|C136.63-2.17 (-1.56%) ▼|CAT781.18-37.37 (-4.56%) ▼|CL88.32+1.54 (+1.77%) ▲|CMCSA25.34+0.14 (+0.56%) ▲|COF208.23-0.02 (-0.01%) ▼|COP139.12+1.75 (+1.27%) ▲|COST915.63+10.86 (+1.20%) ▲|CRM255.22+7.57 (+3.05%) ▲|CSCO110.03-2.10 (-1.87%) ▼|CVS95.72+1.05 (+1.11%) ▲|CVX216.90+2.86 (+1.34%) ▲|DE671.51-4.78 (-0.71%) ▼|DHR201.62+1.53 (+0.76%) ▲|DIS108.32+1.78 (+1.67%) ▲|DUK120.28+0.86 (+0.72%) ▲|EMR147.30-4.86 (-3.19%) ▼|FDX312.04+1.26 (+0.40%) ▲|GD357.16+1.25 (+0.35%) ▲|GE312.74-10.87 (-3.36%) ▼|GEV881.50-75.07 (-7.85%) ▼|GILD144.79+1.07 (+0.74%) ▲|GM86.44+0.82 (+0.96%) ▲|GOOG340.45+5.00 (+1.49%) ▲|GOOGL344.02+5.52 (+1.63%) ▲|GS1,008.54-20.57 (-2.00%) ▼|HD310.18+1.45 (+0.47%) ▲|HON199.13-3.23 (-1.60%) ▼|IBM246.04+2.80 (+1.15%) ▲|INTC95.43-7.51 (-7.30%) ▼|INTU339.11+17.54 (+5.45%) ▲|ISRG375.09+5.94 (+1.61%) ▲|JNJ269.57+3.95 (+1.49%) ▲|JPM353.51-2.77 (-0.78%) ▼|KO89.77+1.51 (+1.71%) ▲|LIN464.39-1.83 (-0.39%) ▼|LLY1,134.64+19.41 (+1.74%) ▲|LMT526.57+2.65 (+0.51%) ▲|LOW198.32+1.51 (+0.76%) ▲|LRCX274.44-23.79 (-7.98%) ▼|MA577.58+8.43 (+1.48%) ▲|MCD257.22+4.71 (+1.86%) ▲|MDLZ63.52+1.08 (+1.73%) ▲|MDT93.48+2.50 (+2.75%) ▲|META659.26+11.23 (+1.73%) ▲|MMM162.80-2.15 (-1.31%) ▼|MO70.96+1.99 (+2.89%) ▲|MRK145.72+1.78 (+1.24%) ▲|MS211.07-3.32 (-1.55%) ▼|MSFT496.53+0.90 (+0.18%) ▲|MU904.89-70.38 (-7.22%) ▼|NEE82.51+0.20 (+0.24%) ▲|NFLX79.77+2.37 (+3.06%) ▲|NKE37.12+0.30 (+0.82%) ▲|NOW140.94+8.41 (+6.34%) ▲|NVDA209.12-9.17 (-4.20%) ▼|ORCL141.79-8.36 (-5.57%) ▼|PEP138.52+2.20 (+1.61%) ▲|PFE27.95+0.26 (+0.94%) ▲|PG147.15+1.93 (+1.33%) ▲|PLTR167.08-0.15 (-0.09%) ▼|PM194.68+3.59 (+1.88%) ▲|QCOM176.50-5.48 (-3.01%) ▼|RTX195.71-1.97 (-1.00%) ▼|SBUX99.41+0.67 (+0.68%) ▲|SCHW107.49+0.24 (+0.22%) ▲|SO87.59+0.42 (+0.48%) ▲|SPG206.18+1.35 (+0.66%) ▲|T26.35+0.29 (+1.09%) ▲|TMO612.55+2.55 (+0.42%) ▲|TMUS185.25+2.92 (+1.60%) ▲|TSLA361.18-4.26 (-1.17%) ▼|TXN262.23-6.47 (-2.41%) ▼|UBER71.61-0.06 (-0.08%) ▼|UNH381.93+5.16 (+1.37%) ▲|UNP284.78+0.38 (+0.13%) ▲|UPS101.25+0.97 (+0.96%) ▲|USB62.98+0.14 (+0.22%) ▲|V375.96+5.51 (+1.49%) ▲|VZ51.13+0.52 (+1.03%) ▲|WFC90.13-0.16 (-0.18%) ▼|WMT108.51+1.36 (+1.27%) ▲|XOM168.43+2.44 (+1.47%) ▲|AAPL332.27+5.70 (+1.75%) ▲|ABBV257.12+2.12 (+0.83%) ▲|ABT104.20+2.20 (+2.15%) ▲|ACN192.45+8.59 (+4.67%) ▲|ADBE263.36+11.13 (+4.41%) ▲|AMAT421.84-34.65 (-7.59%) ▼|AMD484.37-31.76 (-6.15%) ▼|AMGN380.36+3.01 (+0.80%) ▲|AMT177.54-0.33 (-0.19%) ▼|AMZN254.39-2.40 (-0.93%) ▼|AVGO347.05-14.95 (-4.13%) ▼|AXP326.50+1.82 (+0.56%) ▲|BA209.55-0.78 (-0.37%) ▼|BAC62.35-0.34 (-0.53%) ▼|BKNG180.52+6.60 (+3.79%) ▲|BLK1,075.02-4.57 (-0.42%) ▼|BMY64.64+1.02 (+1.60%) ▲|BNY160.77-1.90 (-1.17%) ▼|BRK-B513.81+3.47 (+0.68%) ▲|C136.63-2.17 (-1.56%) ▼|CAT781.18-37.37 (-4.56%) ▼|CL88.32+1.54 (+1.77%) ▲|CMCSA25.34+0.14 (+0.56%) ▲|COF208.23-0.02 (-0.01%) ▼|COP139.12+1.75 (+1.27%) ▲|COST915.63+10.86 (+1.20%) ▲|CRM255.22+7.57 (+3.05%) ▲|CSCO110.03-2.10 (-1.87%) ▼|CVS95.72+1.05 (+1.11%) ▲|CVX216.90+2.86 (+1.34%) ▲|DE671.51-4.78 (-0.71%) ▼|DHR201.62+1.53 (+0.76%) ▲|DIS108.32+1.78 (+1.67%) ▲|DUK120.28+0.86 (+0.72%) ▲|EMR147.30-4.86 (-3.19%) ▼|FDX312.04+1.26 (+0.40%) ▲|GD357.16+1.25 (+0.35%) ▲|GE312.74-10.87 (-3.36%) ▼|GEV881.50-75.07 (-7.85%) ▼|GILD144.79+1.07 (+0.74%) ▲|GM86.44+0.82 (+0.96%) ▲|GOOG340.45+5.00 (+1.49%) ▲|GOOGL344.02+5.52 (+1.63%) ▲|GS1,008.54-20.57 (-2.00%) ▼|HD310.18+1.45 (+0.47%) ▲|HON199.13-3.23 (-1.60%) ▼|IBM246.04+2.80 (+1.15%) ▲|INTC95.43-7.51 (-7.30%) ▼|INTU339.11+17.54 (+5.45%) ▲|ISRG375.09+5.94 (+1.61%) ▲|JNJ269.57+3.95 (+1.49%) ▲|JPM353.51-2.77 (-0.78%) ▼|KO89.77+1.51 (+1.71%) ▲|LIN464.39-1.83 (-0.39%) ▼|LLY1,134.64+19.41 (+1.74%) ▲|LMT526.57+2.65 (+0.51%) ▲|LOW198.32+1.51 (+0.76%) ▲|LRCX274.44-23.79 (-7.98%) ▼|MA577.58+8.43 (+1.48%) ▲|MCD257.22+4.71 (+1.86%) ▲|MDLZ63.52+1.08 (+1.73%) ▲|MDT93.48+2.50 (+2.75%) ▲|META659.26+11.23 (+1.73%) ▲|MMM162.80-2.15 (-1.31%) ▼|MO70.96+1.99 (+2.89%) ▲|MRK145.72+1.78 (+1.24%) ▲|MS211.07-3.32 (-1.55%) ▼|MSFT496.53+0.90 (+0.18%) ▲|MU904.89-70.38 (-7.22%) ▼|NEE82.51+0.20 (+0.24%) ▲|NFLX79.77+2.37 (+3.06%) ▲|NKE37.12+0.30 (+0.82%) ▲|NOW140.94+8.41 (+6.34%) ▲|NVDA209.12-9.17 (-4.20%) ▼|ORCL141.79-8.36 (-5.57%) ▼|PEP138.52+2.20 (+1.61%) ▲|PFE27.95+0.26 (+0.94%) ▲|PG147.15+1.93 (+1.33%) ▲|PLTR167.08-0.15 (-0.09%) ▼|PM194.68+3.59 (+1.88%) ▲|QCOM176.50-5.48 (-3.01%) ▼|RTX195.71-1.97 (-1.00%) ▼|SBUX99.41+0.67 (+0.68%) ▲|SCHW107.49+0.24 (+0.22%) ▲|SO87.59+0.42 (+0.48%) ▲|SPG206.18+1.35 (+0.66%) ▲|T26.35+0.29 (+1.09%) ▲|TMO612.55+2.55 (+0.42%) ▲|TMUS185.25+2.92 (+1.60%) ▲|TSLA361.18-4.26 (-1.17%) ▼|TXN262.23-6.47 (-2.41%) ▼|UBER71.61-0.06 (-0.08%) ▼|UNH381.93+5.16 (+1.37%) ▲|UNP284.78+0.38 (+0.13%) ▲|UPS101.25+0.97 (+0.96%) ▲|USB62.98+0.14 (+0.22%) ▲|V375.96+5.51 (+1.49%) ▲|VZ51.13+0.52 (+1.03%) ▲|WFC90.13-0.16 (-0.18%) ▼|WMT108.51+1.36 (+1.27%) ▲|XOM168.43+2.44 (+1.47%) ▲|
21 C
New York
Monday, September 14, 2026

Tag: share

Industrial Cleaning Solvents Market worth $1.55 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., June 20, 2025 /PRNewswire/ -- The report "Industrial Cleaning Solvents Market by Application (General & Medical Device Cleaning, Metal Cleaners, Disinfectants), End-use Industry (Manufacturing...

Ipsen receives positive CHMP opinion for Cabometyx® in previously treated advanced neuroendocrine tumors

PARIS, FRANCE, 20 June 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for Cabometyx® (cabozantinib) for adult patients with unresectable or metastatic, well differentiated extra-pancreatic (epNET) and pancreatic (pNET) neuroendocrine tumors who have progressed following at least one prior systemic therapy other than somatostatin analogues. This recommendation is based on results from the CABINET Phase III trial presented at the European Society of Medical Oncology (ESMO) Congress 2024 and published in the New England Journal of Medicine.3,4 A final decision on the approval in the European Union is expected in the coming months.

Mowi: Share option scheme for senior executives – attachment

With reference to stock exchange release on 20 June 2025 in relation to allocation of options in Mowi, please see attached allocation details.

GSMA to launch M360 ASEAN 2026 in Kuala Lumpur, Supporting ‘ASEAN 2045: Our Shared Future’

M360 ASEAN is the newly rebranded M360 APAC series, now focused on ASEAN's digital prioritiesAlso bringing the 'Digital Nations Summit to Kuala Lumpur in September...

NurExone Advances U.S. Growth Strategy with Acceptance into Prestigious ARMI HealthTech Hub Accelerator and Provides Corporate Update

TORONTO and HAIFA, Israel, June 20, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biotech company developing exosome-based therapies for central nervous system injuries, announced today that it has been accepted into the HealthTech Hub (“HTH”) Accelerator Program. Based in Boston, Massachusetts, home to more than 1,000 biotech companies1, HTH is operated by the Advanced Regenerative Manufacturing Institute (“ARMI”) and its BioFabUSA initiative.

Deakin University GIFT City Campus, India, announced ‘Winner’ at Economic Times Education Excellence Awards 2025

NEW DELHI, June 20, 2025 /PRNewswire/ -- Deakin University is proud to announce that its GIFT City Campus in Gandhinagar, India, has been awarded...

BC Tech Pioneers Quality Upgrade in PV Industry

SHANGHAI, June 20, 2025 /PRNewswire/ -- During the recent 2025 SNEC exhibition in Shanghai, LONGi, a global leader in PV technology innovation, signed a strategic...

SBI Life crowdsources future-facing AI solutions from India’s Next-Gen Talent pool at the 2025 Hack-AI-Thon finale

The initiative underscored SBI Life's focus on innovation, young talent, and building future-ready insurance solutions MUMBAI, India, June 20, 2025 /PRNewswire/ -- SBI Life Insurance,...

OMS Energy Technologies Inc. Issues Post-IPO Operational Update Featuring Customer Growth, Expansion Initiatives and R&D and Safety Achievements

SINGAPORE, June 19, 2025 (GLOBE NEWSWIRE) -- OMS Energy Technologies Inc. (“OMS” or the “Company”) (Nasdaq: OMSE), a growth-oriented manufacturer of surface wellhead systems (“SWS”) and oil country tubular goods (“OCTG”) for the oil and gas industry, today provided a business update outlining its recent accomplishments as the Company prepares for its inaugural earnings call following its successful Nasdaq listing in May 2025.

Global Times hosts China-Russia Literature Salon in Beijing

BEIJING, June 19, 2025 /PRNewswire/ -- To thoroughly study, promote, and implement Xi Jinping Thought on Culture and to advance mutual learning between Chinese and...

A Date with Light and Shadow Across Thousands of Miles: Beijing International Film Festival Shines in Sydney

BEIJING, CHINA, June 19, 2025 (GLOBE NEWSWIRE) -- This year, the Beijing International Film Festival made its Australian debut, hosting a special promotional event on June 13 during the 72nd Sydney International Film Festival, marking a fresh encounter between Chinese cinematic culture and audiences in the Southern Hemisphere. Australia is a land that has not only nurtured a rich and unique geographical landscape but has also produced diverse masterpieces that have made their mark on the international film scene, such as "Memoir of a Snail," "Hacksaw Ridge," "Mad Max: Fury Road," and "Moulin Rouge." As the country's most representative film event, the Sydney International Film Festival brings together outstanding films and creators from around the world, allowing this harbor city to showcase its unique cultural charm through the interplay of light and shadow.

Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025

MELBOURNE, Australia and INDIANAPOLIS, June 20, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces five abstract presentations and two satellite symposia featuring its developmental theranostic programs and commercial products at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2025 Annual Meeting being held in New Orleans, Louisiana (U.S.) from June 21 – 24.

FinVolution Group Announces Proposed Offering of US$130 Million Convertible Senior Notes

SHANGHAI, June 19, 2025 /PRNewswire/ -- FinVolution Group ("FinVolution" or the "Company") (NYSE: FINV), a leading fintech platform in China, Indonesia and the Philippines,...

Shipsy to Drive Rapid Expansion in Australia, Establishes Regional Headquarters in Sydney to Support Growing Client Base

SYDNEY, June 20, 2025 /PRNewswire/ -- Shipsy, a Gartner-recognized global leader in AI-powered SaaS-based logistics management platform provider, recently announced its plans to aggressively...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsShare